NBHL is committed to discovering First-In-Class medicines for the unmet medical needs with the sophisticated drug discovery platforms ( Monoclonal Antibody for GPCR and Small compounds ). We are looking for the pharmaceutical partners to develop the following projects. We are available for the project-based Drug discovery alliance, using our drug discovery platforms powered by PerkinElmer, and Biotech companies.
